Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Placenta accreta spectrum (PAS) is a serious pregnancy condition compromising the trophoblastic invasion of the placenta or part of it into the myometrium. It is mainly treated by hysterectomy which may leave many complications on the long term mainly infertility. Nonetheless, the desire to preserve fertility has prompted investigation into fertility-preserving alternatives, most notably the off-label use of methotrexate, despite limited consensus on its efficacy or safety. The aim of this review is to assess the efficacy of methotrexate in treating PAS based on pregnancy trimesters.
Methods: A search of different databases was performed, extracting the relevant information.
Results And Discussion: This part is divided into two major parts: the use of methotrexate alone and the use of combination therapies including methotrexate. The former was mainly used in the third trimester according to the selected literature, and postpartum while the latter was used in different trimesters. Out of 27 articles, 63% demonstrated a favorable response to methotrexate. However, the outcome has shown no change between different gestational ages.
Conclusion: Despite guideline recommendations, methotrexate may serve as a viable conservative option in carefully selected hemodynamically stable patients, warranting further investigation. Further large-scale studies stratified by trimester or patient population are needed to assess its safety and efficacy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401312 | PMC |
| http://dx.doi.org/10.1097/MS9.0000000000003524 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The epidemiology, clinical burden, and prevention of intrauterine adhesions (IUAs) related to surgically induced endometrial trauma: a systematic literature review and selective meta-analyses.
Hum Reprod Update
September 2025
Women's Health Research Collaborative, New York, NY, USA.
Background: Reproductive-age women with intrauterine adhesions (IUAs) following uterine surgery may be asymptomatic or may experience light or absent menstruation, infertility, preterm delivery, and/or peripartum hemorrhage. Understanding procedure- and technique-specific risks and the available evidence on the impact of surgical adjuvants is essential to the design of future research.
Objective And Rationale: While many systematic reviews have been published, most deal with singular aspects of the problem.
Effect of an emergency/planned cesarean section on the perinatal outcomes of pregnant women with placenta accreta spectrum and their neonates: a retrospective study cohort.
Front Surg
August 2025
Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Background: Placenta accreta spectrum (PAS) is an obstetric condition. This study analyzes the outcomes of PAS parturients and their newborns undergoing emergency cesarean sections as opposed to planned cesarean sections.
Methods: In this research, we conduct a thorough retrospective analysis of 345 patients with placenta accreta at a single medical center.
Maternal and perinatal outcomes in women aged 50 years and older: A nationwide cross-sectional study.
J Obstet Gynaecol Res
September 2025
Department of Obstetrics and Gynecology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Aim: This study aimed to investigate maternal and perinatal outcomes in pregnancies among women aged50-54 and 55-59, to refine risk assessments and inform evidence-based counseling and perinatal management guidelines.
Methods: A nationwide registry maintained by the Japan Society of Obstetrics and Gynecology identified pregnancies between January 2013 and December 2022. Analyses included women aged 45-59 years with assisted reproductive technology pregnancies, excluding triplet or higher-order multiple gestations.
The use of methotrexate in the management of placenta accreta spectrum: a narrative review.
Ann Med Surg (Lond)
September 2025
Faculty of Medicine, Université Saint Joseph, Beirut, Lebanon.
Introduction: Placenta accreta spectrum (PAS) is a serious pregnancy condition compromising the trophoblastic invasion of the placenta or part of it into the myometrium. It is mainly treated by hysterectomy which may leave many complications on the long term mainly infertility. Nonetheless, the desire to preserve fertility has prompted investigation into fertility-preserving alternatives, most notably the off-label use of methotrexate, despite limited consensus on its efficacy or safety.
View Article and Find Full Text PDFAgainst All Odds: Treating Septic Shock and Massive Hemorrhage in a Patient With Placenta Accreta.
Cureus
July 2025
Department of Anesthesiology, Critical Care and Pain Medicine, University of Texas Health Science Center at Houston, Houston, USA.
Placenta accreta spectrum (PAS), maternal sepsis, and hemorrhagic shock remain significant contributors to maternal morbidity and mortality. We present the case of a 36-year-old female with placenta accreta and preterm premature rupture of membranes (PPROM) who developed septic shock and underwent an emergent cesarean hysterectomy at 28 weeks of gestation. Her intraoperative course was complicated by massive hemorrhage with an estimated blood loss of 40 liters, cardiac arrest, and disseminated intravascular coagulation (DIC).
View Article and Find Full Text PDF